Clinical Trial Update: Study of Rifaximin in Minimal Hepatic Encephalopathy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating rifaximin in patients with minimal hepatic encephalopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Minimal Hepatic Encephalopathy

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Hunter Holmes Mcguire Veteran Affairs Medical Center | Conditions: Minimal Hepatic Encephalopathy | Phase 1, Phase 2 | Status: COMPLETED